REGEN BIOPHARMA, INC. Available-for-sale Equity Securities, Gross Unrealized Loss
REGEN BIOPHARMA, INC. (RGBP) reported Available-for-sale Equity Securities, Gross Unrealized Loss of $8.00 thousand for the 6-month period ending 2017-03-31, per its 10-Q filed 2017-05-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedLoss · last filed 2017-05-05
- REGEN BIOPHARMA, INC. available-for-sale equity securities, gross unrealized loss for the quarter ending 2017-03-31 was -$192.00K, a 403.80% decline year-over-year.
- REGEN BIOPHARMA, INC. available-for-sale equity securities, gross unrealized loss for the quarter ending 2016-12-31 was $200.00K.
- REGEN BIOPHARMA, INC. available-for-sale equity securities, gross unrealized loss for the quarter ending 2016-09-30 was $46.40K.
- REGEN BIOPHARMA, INC. available-for-sale equity securities, gross unrealized loss for the quarter ending 2016-06-30 was $23.20K.
| Period end | Available-for-sale Equity Securities, Gross Unrealized Loss 3 month | Available-for-sale Equity Securities, Gross Unrealized Loss 6 month | Available-for-sale Equity Securities, Gross Unrealized Loss 9 month | Available-for-sale Equity Securities, Gross Unrealized Loss 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$192.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-05-05 | $8.00K 10-Q · filed 2017-05-05 | $54.40K derived: sum of 3 quarters · filed 2017-05-05 | $77.60K derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-12-31 | $200.00K 10-Q/A · filed 2017-04-28 | $246.40K derived: sum of 2 quarters · filed 2017-04-28 | $269.60K derived: sum of 3 quarters · filed 2017-04-28 | $332.80K derived: sum of 4 quarters · filed 2017-04-28 |
| 2016-09-30 | $46.40K 10-K/A · filed 2017-04-28 | $69.60K derived: sum of 2 quarters · filed 2017-04-28 | $132.80K derived: sum of 3 quarters · filed 2017-04-28 | |
| 2016-06-30 | $23.20K 10-Q/A · filed 2017-04-28 | $86.40K derived: sum of 2 quarters · filed 2017-04-28 | ||
| 2016-03-31 | $63.20K 10-Q/A · filed 2017-04-28 |